MedTrace Logo

FIFA 11+ in Young Female Volleyball Players

NCT07733648 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-07-29

No results posted yet for this study

Summary

This study aims to investigate the effects of an 8-week FIFA 11+ exercise program on wellness, rating of perceived exertion (RPE), dynamic balance, and single-leg functional performance in young female volleyball players, as well as to examine the relationships among these variables. The study will also evaluate the program's effects on injury incidence and fear of reinjury.

The study is original in applying the FIFA 11+, a well-established injury prevention program, to volleyball and evaluating its effects together with training-load parameters through a multidimensional approach. It is expected to contribute to the literature by proposing a comprehensive model for monitoring athletic performance and injury risk in young female volleyball players.

Conditions

  • Sport Injuries

Interventions

OTHER

FIFA 11

Participants will undergo an 8-week non-intervention control period followed by a 2-week washout period and an 8-week FIFA 11+ exercise program in addition to regular volleyball training. The program consists of structured running, strength, balance, plyometric, and agility exercises. Wellness, rating of perceived exertion, dynamic balance, single-leg functional performance, injury incidence, and fear of reinjury will be assessed before and after the relevant study periods.

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-10
Primary Completion
2026-11-10
Completion
2027-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07733648 on ClinicalTrials.gov